Insight on Itropine for Patients

With myopia prevalence and severity on the rise, myopia control has been a spotlight for treatment. Itropine treatment is simple compared to other management options of hard and soft specialty contacts. Research also corroborates the safety and efficacy of Itropine’s specific dosage.

Itropine comes in convenient, single dose vials to avoid cross contamination, making them simple to use and easy to apply. Its preservative free nature protects and enhances the ocular surface by promoting lubricant relief, helping to avoid symptoms of allergies and dryness.

The purpose of Itropine is to provide an option to control how rapidly nearsightedness advances. This early intervention can decrease the dangers of severe myopia and its subsequent risks. Otherwise, myopia will run its normal course, increasing susceptibility to pathological myopia diseases.

Itropine can reduce long term quality of life implications of high myopia as well. This is an important consideration as certain situations may arise where one may be uncorrected and unable to perform important tasks quickly or efficiently. Moreover, patients can be disqualified from particular future occupations due to failing their visual requirements or parameters